Wellgistics Health (WGRX) has entered into an amendment to the Membership Interest Purchase Agreement with Wellgistics and Wellgistics former owners to convert a significant cash payment owed by the Company into shares of the Company’s common stock at the initial public offering price of $4.50 per share. Specifically, the Company has converted $1.5M in debt that the Company owed to a seller entity controlled by Brian Norton, its CEO and that the Company would have needed to pay by June 14, 2025. The $1.5M in debt was converted into 333,333 shares of the Company’s common stock. This conversion reflects Mr. Norton’s deep belief in the Company’s strategic direction and his commitment to creating long-term shareholder value. Further reinforcing Mr. Norton’s belief in the Company’s long-term success, the 333,333 newly issued shares of the Company’s common stock are subject to a 12-month lock-up agreement, whereby Mr. Norton is prohibited, except in certain limited exceptions, from selling or transferring such shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGRX:
- Wellgistics Health Acquires Peek Healthcare Technologies
- Wellgistics Health to acquire Peek Healthcare Technologies, terms not disclosed
- Wellgistics Health Expands with AI and Public Transition
- Wellgistics Health shares annual letter to shareholders
- Wellgistics Health Achieves SOC 2 Type 1 Compliance
